VentiRx Pharmaceuticals

VentiRx Pharmaceuticals develops novel TLR8 therapeutics for the treatment of cancer, allergy, and respiratory and autoimmune diseases.

VentiRx Pharmaceuticals operates in biotechnology, health care, therapeutics based in Greater Seattle Area, West Coast, Western US, founded in 2006.

The company sits in the biotechnology, health care, therapeutics segment, where it competes on its core product or service.

Greater Seattle Area, West Coast, Western US is where the company is located.

Its current recorded stage is Series_B.

Recorded headcount: c_00011_00050 employees.

Public records show total funding of about $104.5M.

Sector	Biotechnology, Health Care, Therapeutics
Headquarters	Greater Seattle Area, West Coast, Western US
Founded	2006
Employees	c_00011_00050
Stage	series_b
Total funding	$104,502,514

Website: www.ventirx.com

Contact details and direct channels are available to signed-in members.
Create a free account

Browse related